#LegendNews at #EHA2026. We’ll present initial Phase 1 LB2501 data in relapsed/refractory B-cell NHL in a late-breaking oral presentation. The abstract highlights encouraging clinical activity and a favorable safety profile.
Learn more: https://t.co/1lTEqrcu00
@EHA_Hematology
We asked a few of our leaders what they’re most excited about heading into the weekend. Their response wasn’t a single study or session. Instead, it highlighted the momentum across the oncology community. #ASCO26
The energy at #ASCO26 feels different this year. More conversations around earlier intervention. More momentum behind cell therapy. More urgency around what comes next. A few reflections from the Legend team onsite today.
#LegendNews: Early LB2102 data in solid tumors will be presented at #ASCO26.
Additional data presented at @ASCO reinforce established efficacy and safety profile in #MultipleMyeloma.
Come find us at ASCO Booth #21955 to learn more and read more at: https://t.co/BZuAPKZwIF
At @ASCO, we'll present new data across our cell therapy portfolio, including investigational LB2102 findings in solid tumors and our CAR-T program in multiple myeloma. We remain focused on advancing cell therapy innovation and oncology research.
#ASCO26#CellTherapy
#LegendNews: Legend has engaged leading scientific advisors to help guide the advancement of our pipeline and next-generation cell therapy innovation. Their expertise across oncology, immunology & translational science will help shape our R&D strategy.
🔗https://t.co/xLcU7pgrXM
ICYMI: we recently celebrated the opening of our new 32,000 square foot state-of-the-art cell therapy research facility in downtown Philadelphia that will help support Legend’s pipeline of next-generation cell therapies. For more about Legend’s pipeline: https://t.co/cSCIgPUQbo.
@EmeliaBenjamin shared great data to support reduce risk of AFib: 10% weight loss, 210 mins of exercise per week, quit smoking, minimize/eliminate alcohol, optimal blood pressure control #StopAfib24
Afib risk factors…obesity, sendentary lifestyle, alcohol. @EmeliaBenjamin shares, you know how you have someone go walk your dog, have someone go to walk your mom. Let’s postpone the inevitable as long as possible #stopafib24
Lifetime risk of AFib is going up shares @EmeliaBenjamin . If you have unexplained shortness of breath, pay attention. Need more evidence to prevent onset of HF.
16a) A reminder: #etripamil is a novel, investigational, L-type #calcium channel blocker that has been formulated for intranasal 👃spray with:
⚡️Rapid onset (Tmax ≤ 7 min)
⚡️Short-lasting plasma exposure due to inactivation by blood esterases, but outlasted by clinical effect
1) The fact that the pandemic has disconvenienced you doesn’t mean that is hasn’t been catastrophic for others.
2) The public health policies that chaff & irritate you are intended to limit the catastrophic impact of the pandemic.
3) Be thankful you get to be only inconvenienced